Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Munro

Showing results (231-240 of 247) with videos related to

Pageof 25
Sort By:
Biochemistry|December 22, 2004
Interaction of nitric oxide with cytochrome P450 BM3Luca G Quaroni, Harriet E Seward, Kirsty J McLean, et al.
Proteins|April 21, 2026
The Mycobacterium tuberculosis Rv0132c Gene Product Mtb-FGD2 Can Act as an F<sub>420</sub>-Dependent Glucose DehydrogenaseAdewale V Aderemi, Matthew Snee, Richard B Tunnicliffe, et al.
Biochemical Society Transactions|July 27, 2005
Flavocytochrome P450 BM3: an update on structure and mechanism of a biotechnologically important enzymeA J Warman, O Roitel, R Neeli, et al.
Trends in Biochemical Sciences|June 22, 2002
P450 BM3: the very model of a modern flavocytochromeAndrew W Munro, David G Leys, Kirsty J McLean, et al.
The Journal of Biological Chemistry|September 27, 2008
Characterization of active site structure in CYP121. A cytochrome P450 essential for viability of Mycobacterium tuberculosis H37RvKirsty J McLean, Paul Carroll, D Geraint Lewis, et al.
Chemistryopen|August 2, 2019
Design and Synthesis of Imidazole and Triazole Pyrazoles as <i>Mycobacterium Tuberculosis</i> CYP121A1 InhibitorsSafaa M Kishk, Kirsty J McLean, Sakshi Sood, et al.
Journal of Medicinal Chemistry|March 23, 2016
Fragment-Based Approaches to the Development of Mycobacterium tuberculosis CYP121 InhibitorsMadeline E Kavanagh, Anthony G Coyne, Kirsty J McLean, et al.
Biochemical Society Transactions|July 27, 2005
Biodiversity of cytochrome P450 redox systemsK J McLean, M Sabri, K R Marshall, et al.
The Journal of Biological Chemistry|December 10, 2016
Structural Characterization and Ligand/Inhibitor Identification Provide Functional Insights into the Mycobacterium tuberculosis Cytochrome P450 CYP126A1Jude T Chenge, Le Van Duyet, Shalini Swami, et al.
Biorxiv : the Preprint Server for Biology|January 13, 2025
Fragment-based development of small molecule inhibitors targeting <i>Mycobacterium tuberculosis</i> cholesterol metabolismMadeline E Kavanagh, Kirsty J McLean, Sophie H Gilbert, et al.
Pageof 25

Showing results (231-240 of 247) with videos related to

Sort By:
Pageof 25
Biochemistry|December 22, 2004
Interaction of nitric oxide with cytochrome P450 BM3Luca G Quaroni, Harriet E Seward, Kirsty J McLean, et al.
Proteins|April 21, 2026
The Mycobacterium tuberculosis Rv0132c Gene Product Mtb-FGD2 Can Act as an F<sub>420</sub>-Dependent Glucose DehydrogenaseAdewale V Aderemi, Matthew Snee, Richard B Tunnicliffe, et al.
Biochemical Society Transactions|July 27, 2005
Flavocytochrome P450 BM3: an update on structure and mechanism of a biotechnologically important enzymeA J Warman, O Roitel, R Neeli, et al.
Trends in Biochemical Sciences|June 22, 2002
P450 BM3: the very model of a modern flavocytochromeAndrew W Munro, David G Leys, Kirsty J McLean, et al.
The Journal of Biological Chemistry|September 27, 2008
Characterization of active site structure in CYP121. A cytochrome P450 essential for viability of Mycobacterium tuberculosis H37RvKirsty J McLean, Paul Carroll, D Geraint Lewis, et al.
Chemistryopen|August 2, 2019
Design and Synthesis of Imidazole and Triazole Pyrazoles as <i>Mycobacterium Tuberculosis</i> CYP121A1 InhibitorsSafaa M Kishk, Kirsty J McLean, Sakshi Sood, et al.
Journal of Medicinal Chemistry|March 23, 2016
Fragment-Based Approaches to the Development of Mycobacterium tuberculosis CYP121 InhibitorsMadeline E Kavanagh, Anthony G Coyne, Kirsty J McLean, et al.
Biochemical Society Transactions|July 27, 2005
Biodiversity of cytochrome P450 redox systemsK J McLean, M Sabri, K R Marshall, et al.
The Journal of Biological Chemistry|December 10, 2016
Structural Characterization and Ligand/Inhibitor Identification Provide Functional Insights into the Mycobacterium tuberculosis Cytochrome P450 CYP126A1Jude T Chenge, Le Van Duyet, Shalini Swami, et al.
Biorxiv : the Preprint Server for Biology|January 13, 2025
Fragment-based development of small molecule inhibitors targeting <i>Mycobacterium tuberculosis</i> cholesterol metabolismMadeline E Kavanagh, Kirsty J McLean, Sophie H Gilbert, et al.
Pageof 25